Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ondine Biomedical Inc.

www.ondinebiopharma.com

Latest From Newdeal Technologies

Integra LifeSciences: Mid-Sized Company in Big Company Clothing

Founded in 1989 Integra avoided the sad fates of its peers in tissue engineering (which went bankrupt) by adopting an acquisition strategy that took it into surgical product markets. Integra has enjoyed a compound annual revenue growth rate of 36% since it first embarked on its acquisition strategy in 1999. Its secret of success has been to consolidate fragmented niche markets into which it can create additional value by selling its internally-developed tissue-engineered products. Now, with six operating divisions covering four surgical specialties with a multiplicity of call points, it looks and acts like a large, diversified medical device company. But it's not-with $650 million in revenues, it's a mid-sized company. Can it now, as a mid-sized company with a complicated business, sustain its high level of growth through a combination of acquisitions and organic growth?
Medical Device Business Strategies

Joint Resurfacing: Boom or Bust?

One of the hottest topics at the 2007 AAOS was the the trend toward resurfacing rather than completely replacing joints damaged by arthritis and other causes. There are a variety of metallic, synthetic and biologic methods used in hip, knee, shoulder and extremity joint resurfacing, many designed for younger patients who wish to remain active and avoid total joint replacement.
Medical Device Platform Technologies
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
    • Laser
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Pharmaceuticals
  • Therapeutic Areas
  • Dental & Oral Products
  • Infectious & Viral Diseases
  • Wound Healing & Tissue Repair
  • Alias(es)
  • Ondine Biopharma Corp.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • Canada
  • Parent & Subsidiaries
  • Ondine Biomedical Inc.
  • Senior Management
  • Carolyn Cross, Chmn. & CEO
    William S Harper, CFO & VP, Fin.
    Nicholas G Loebel, PhD, Pres. & CTO
    Cale Street, PhD, VP, Rsch.
  • Contact Info
  • Ondine Biomedical Inc.
    Phone: (604) 669-0555
    888-1100 Melville St.
    Vancouver, V6E 4A6
    Canada
Advertisement
Advertisement
UsernamePublicRestriction

Register